Valuation : BOIRON

Market Cap 451M 524M 427M 387M 727M 50.05B 731M 5.08B 1.95B 25.47B 1.97B 1.92B 80.47B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 404M 468M 382M 346M 650M 44.75B 653M 4.54B 1.75B 22.77B 1.76B 1.72B 71.94B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week+0.77%
Current month+0.77%
1 month-1.51%
3 months-7.45%
6 months-0.95%
Current year-12.42%
1 week 25.9
Extreme 25.9
26.1
1 month 25.7
Extreme 25.7
26.5
3 years 20.5
Extreme 20.5
55.9
5 years 20.5
Extreme 20.5
55.9
10 years 20.5
Extreme 20.5
91.9
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.77%+11.06%-51.12% 524M
0.00%-1.22%-14.56%-5.64% 13.4B
-1.27%-3.07%-33.48%-56.88% 4.78B
-0.61%-5.58%-5.83%-6.20% 4.36B
-1.49%-4.28%-11.69%-32.46% 3.78B
-1.37%-3.98%-25.66%+0.79% 3.43B
-2.78%-3.65%-4.32%-5.13% 3.41B
-0.85%-4.82%-13.72%+3.39% 3.12B
-1.30%-2.63%-24.61%-18.99% 2.27B
-2.13%-2.81%-29.80%-20.08% 1.63B
Average -1.31%-2.87%-15.26%-19.23% 4.47B
Weighted average by Cap. -0.94%-2.27%-16.44%-14.84%

Financials

2024 2025
Net sales 488M 566M 462M 418M 785M 54.06B 789M 5.48B 2.11B 27.5B 2.13B 2.08B 86.91B 501M 582M 474M 430M 807M 55.56B 811M 5.64B 2.17B 28.27B 2.18B 2.14B 89.32B
Net income 11.34M 13.16M 10.73M 9.73M 18.25M 1.26B 18.34M 127M 49.02M 639M 49.41M 48.33M 2.02B 32.64M 37.89M 30.91M 28.02M 52.56M 3.62B 52.83M 367M 141M 1.84B 142M 139M 5.82B
Net Debt -49.74M -57.73M -47.1M -42.69M -80.08M -5.52B -80.49M -559M -215M -2.81B -217M -212M -8.87B -47.86M -55.54M -45.31M -41.07M -77.05M -5.31B -77.44M -538M -207M -2.7B -209M -204M -8.53B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
-
Date Price Change
26-09-11 €26.10 0.00%
26-09-10 €26.10 0.00%
26-09-09 €26.10 0.00%
26-09-08 €26.10 0.00%
26-09-07 €26.10 +0.77%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!